Price $108.39 |
Market Cap
8.13B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.4
|
P/S
2.25
|
Dividend %
-
|
|
P/CF
16.2
|
P/FCF
6.6
|
Op. Cash Flow
1.38M
|
FCF
20.1
|
|
Op. Margin
1.20%
|
Net Margin
-2.30%
|
ROE
-2.70%
|
ROI
1.10%
|
|
ROA
-0.80%
|
EPS Growth
-64.30%
|
Current Ratio
2.8
|
Debt/Equity
184.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
| Generation Bio Co (GBIO) | $2.32 | - | - | 65.9M | Strong Buy |
| Pharmacyte Biotech Inc (PMCB) | $1.65 | - | - | 18.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
